# MOTS-c: research reference

For research use only. Checked November 1, 2026.

MOTS-c is a 16-residue mitochondrial-derived peptide described in research on metabolic signaling. A foundational paper investigated cellular metabolism and mouse metabolic models; later work examined movement into the nucleus during cellular stress. Those studies frame MOTS-c as a signaling research topic. They do not establish personal-use outcomes, validate commercial products, or turn a measured pathway response into a general longevity claim.

## Identity
MOTS-c is named for a short open reading frame associated with the mitochondrial 12S ribosomal-RNA region. The literature's sequence-defined research material must be distinguished from a catalog label and from other mitochondrial-derived peptides. Identity, formulation and lot-specific analysis remain separate documentation questions for any supplied material.

## Mechanism
The 2015 study linked MOTS-c experiments with folate/purine metabolism and AMPK signaling in its models. The mechanistic interest is communication between mitochondrial genetic information and broader cellular metabolic responses, not a demonstrated universal increase in cellular energy.

The 2018 work investigated stress-associated nuclear localization and gene regulation, including an AMPK-dependent component. Subcellular movement and transcriptional changes provide experimentally testable hypotheses; they are not direct measures of organismal lifespan or a finished product's performance.

## Selected research
### A mitochondrial-derived signaling candidate
Model: Cell experiments and mouse metabolic models

Lee and colleagues described MOTS-c and reported changes in metabolic signaling and selected mouse metabolic outcomes.

Limitation: The selected models cannot independently establish clinical outcomes or transferability to a different preparation.

### Stress-associated nuclear communication
Model: Cellular metabolic-stress experiments

Kim and colleagues reported nuclear localization and changes in nuclear gene regulation associated with MOTS-c under metabolic stress.

Limitation: Cellular localization and transcription endpoints need to be distinguished from whole-organism effects; pathway dependence is context-specific.

## Open questions
- Which cellular contexts reproduce the same localization and signaling patterns? Cell type, stress model and measured compartment can change the research question.
- How does the sequence-defined experimental material compare with a supplied reference reagent in identity, content and formulation? A published name alone does not answer that question.
- Which downstream changes are required for the measured phenotype, rather than associated with it? Separating pathway activation from causal necessity makes the next experiment more informative.
- These selected papers do not constitute a comprehensive current trial review. They cannot establish human effectiveness, long-term safety, or an appropriate personal-use protocol, and none is proposed here.

## Storage and handling
The cited signaling papers are not a universal storage specification. Use the documentation for the exact dry material or solution and preserve its formulation and lot identifiers.

Do not infer a shelf life or stability claim from a pathway study. A stability question requires its own conditions, sampling and suitable analytical method.

## Sources
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (2015). https://pubmed.ncbi.nlm.nih.gov/25738459/
- The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress (2018). https://pubmed.ncbi.nlm.nih.gov/29983246/

For research use only. Primary abstracts and identifiers checked November 1, 2026. Selected primary literature, not a systematic review. The 2018 paper discloses a consultant/shareholder relationship for one author; check its full conflict statement when appraising the study.